OptimizeRx Corp — Director's Dealing 2025

Oct 7, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2025-08-21

Reporting Person: D'Silva Andrew J. (Chief Business Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-21	Common Stock	A	10417	—	Acquired	47514	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-08-21	Stock Option	$16.14	A	23437	Acquired	2030-08-21	Common Stock (23437)	Direct

Footnotes

F1: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date.

F2: The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date.